Vincristine
Common brands: Cyclophosphamide, Frindovyx, Doxorubicin Hydrochloride, Methotrexate, Prednisone
Top reporter: Hospira, Inc.
Corticosteroid [EPC]Alkylating Drug [EPC]CD20-directed Cytolytic Antibody [EPC]Folate Analog Metabolic Inhibitor [EPC]Nucleoside Metabolic Inhibitor [EPC]
28,660
Total Reports
14,030
Serious Reports
5,333
Death Reports
30
Reported Reactions
Death Report Ratio: High (18.61%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Vincristine.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | FEBRILE NEUTROPENIA | 4,315 | |
| 2 | PYREXIA | 1,874 | |
| 3 | NEUTROPENIA | 1,720 | |
| 4 | OFF LABEL USE | 1,690 | |
| 5 | SEPSIS | 1,084 | |
| 6 | VOMITING | 1,012 | |
| 7 | DISEASE PROGRESSION | 999 | |
| 8 | NAUSEA | 941 | |
| 9 | PANCYTOPENIA | 918 | |
| 10 | PNEUMONIA | 913 | |
| 11 | HYPOTENSION | 870 | |
| 12 | THROMBOCYTOPENIA | 834 | |
| 13 | DEATH | 824 | |
| 14 | DRUG INEFFECTIVE | 824 | |
| 15 | ANAEMIA | 806 | |
| 16 | DIARRHOEA | 759 | |
| 17 | ABDOMINAL PAIN | 749 | |
| 18 | WHITE BLOOD CELL COUNT DECREASED | 728 | |
| 19 | MYELOSUPPRESSION | 716 | |
| 20 | PRODUCT USE IN UNAPPROVED INDICATION | 692 | |
| 21 | INTERSTITIAL LUNG DISEASE | 680 | |
| 22 | MUCOSAL INFLAMMATION | 664 | |
| 23 | SEPTIC SHOCK | 659 | |
| 24 | NEOPLASM PROGRESSION | 649 | |
| 25 | PLATELET COUNT DECREASED | 645 | |
| 26 | NEUROPATHY PERIPHERAL | 633 | |
| 27 | NEUTROPHIL COUNT DECREASED | 588 | |
| 28 | SECOND PRIMARY MALIGNANCY | 567 | |
| 29 | FATIGUE | 545 | |
| 30 | INFECTION | 534 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.